AB0327 SERUM IRISIN LEVELS IN HEALTHY WOMEN AND PATIENTS WITH RHEUMATOID ARTHRITIS. (2nd June 2020)

• Record Type: Journal Article
• Authors: Yury, A.; Zavodovsky, В.; J, P.; L, S.; Papichev, E.; Lavrova, D.
• Is Part Of: Annals of the rheumatic diseases. Volume 79(2020)Supplement 1
• Page Start: 1462
• Page End: 1462
• Publication Date: 2020-06-02
• Subjects: Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2020-eular.1666
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Objectives: to study serum irisin levels in healthy females and patients with rheumatoid arthritis. Methods: We examined 110 patients with a reliable diagnosis of rheumatoid arthritis (RA). The age of the examined was from 18 to 69 years, all patients were female. The diagnosis of RA was established on the basis of the 2010 EULAR diagnostic criteria. The group of patients included patients with a diagnosis at least one month before the planned screening. As a control group, as well as to create a representation of the normal values irisina level in the blood serum of healthy persons were examined 60 healthy volunteers (all women). In both groups, the level of serum irisin was determined using the enzyme-linked immunosorbent assay by the commercial Irisin ELISA kit. Results: As a result of measurements in the group of healthy individuals, the average value with the standard deviation used to assess the reliability of the average values was 20.49±4.82 μg/ml (μ±σ). By calculation, a reference interval of 10.85-30.13 μg/ml was determined, defined as μ±2σ. In patients with RA, the level of serum irisin was 14.52±6.99 μg / ml (μ±σ), which is significantly lower than in healthy individuals (p<0.01). Then we divided all patients into 2 groups: group 1 with normal values (66 people), group 2 (44 patients) - with a reduced (less than 10.85 μg/ml) level of irisin. In both groups, the dynamics of the level of serum irisin was studied depending on the duration of the disease. Among patients with a disease RA duration of less than 4 years, 16 (24.24%) patients had a normal level of irisin, and 14 (31.82%) had a reduced level (less than 10.85 μg/ml). Among patients with a disease duration of more than 10 years, 36 (54.55%) patients had a normal level of serum irisin, and a low level was determined in 16 (36.36%) patients (χ 2 =3.568, p=0.168). Conclusion: According to the data obtained, the normal level of serum irisin in healthy female individuals was 10.85-30.13 μg/ml. In patients with RA, the average level of irisin is significantly lower, however, with an increase in the duration of the disease, it tends to normalize. Disclosure of Interests: None declared